SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027277
Filing Date
2023-06-09
Accepted
2023-06-09 16:29:10
Documents
13
Period of Report
2023-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-20230608.htm   iXBRL 8-K 393701
2 EX-3.1 crsp-ex3_1.htm EX-3.1 690624
  Complete submission text file 0000950170-23-027277.txt   1285353

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20230608.xsd EX-101.SCH 2464
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20230608_lab.xml EX-101.LAB 13473
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20230608_pre.xml EX-101.PRE 10966
7 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20230608_htm.xml XML 4681
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 231005729
SIC: 2836 Biological Products, (No Diagnostic Substances)